Centruroides immune Fab (equine) - Instituto Bioclon/Rare Disease Therapeutics
Alternative Names: Anascorp; Scorpion immune Fab (equine)Latest Information Update: 18 Mar 2015
At a glance
- Originator Instituto Bioclon
- Developer Instituto Bioclon; Rare Disease Therapeutics
- Class Antibodies; Antivenins; Fab fragments
- Mechanism of Action Scorpion venom inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Marketed Scorpion venom poisoning